Agilent Technologies Inc (A) : R.h. Dinel Investment Counsel reduced its stake in Agilent Technologies Inc by 8.59% during the most recent quarter end. The investment management company now holds a total of 12,235 shares of Agilent Technologies Inc which is valued at $567,826 after selling 1,150 shares in Agilent Technologies Inc , the firm said in a disclosure report filed with the SEC on Jul 11, 2016.Agilent Technologies Inc makes up approximately 0.65% of R.h. Dinel Investment Counsel’s portfolio.
Other Hedge Funds, Including , Thompson Rubinstein Investment Management Inc Or boosted its stake in A in the latest quarter, The investment management firm added 1,200 additional shares and now holds a total of 73,032 shares of Agilent Technologies Inc which is valued at $3,321,495. Agilent Technologies Inc makes up approx 1.27% of Thompson Rubinstein Investment Management Inc Or’s portfolio.Chevy Chase Trust Holdings boosted its stake in A in the latest quarter, The investment management firm added 2,738 additional shares and now holds a total of 282,686 shares of Agilent Technologies Inc which is valued at $12,856,559. Agilent Technologies Inc makes up approx 0.07% of Chevy Chase Trust Holdings’s portfolio.Washington Trust Bank reduced its stake in A by selling 150 shares or 75.76% in the most recent quarter. The Hedge Fund company now holds 48 shares of A which is valued at $2,183.Integrated Investment Consultants reduced its stake in A by selling 66 shares or 4.13% in the most recent quarter. The Hedge Fund company now holds 1,531 shares of A which is valued at $66,981. Agilent Technologies Inc makes up approx 0.04% of Integrated Investment Consultants’s portfolio.
Agilent Technologies Inc closed down -0.12 points or -0.26% at $46.41 with 18,52,475 shares getting traded on Wednesday. Post opening the session at $46.64, the shares hit an intraday low of $46.325 and an intraday high of $46.82 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
On the company’s financial health, Agilent Technologies Inc reported $0.44 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on May 16, 2016. Analyst had a consensus of $0.39. The company had revenue of $1019.00 million for the quarter, compared to analysts expectations of $983.35 million. The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.38 EPS.
Many Wall Street Analysts have commented on Agilent Technologies Inc. Company shares were Reiterated by Jefferies on May 17, 2016 to “Buy”, Firm has raised the Price Target to $ 51 from a previous price target of $46 .Company shares were Reiterated by Barclays on May 17, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 45 from a previous price target of $42 .
Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.